Treatment of pertussis with pertussis immune globulin

Rolando C. Balagtas, Kenrad E. Nelson, Stuart Levin, Samuel P. Gotoff

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Children with pertussis were treated with 2.5 c.c. of pertussis immune globulin or placebo in double-blind fashion. Patients were generally in the first week of the paroxysmal stage, and treatment and control groups were comparable. All children received ampicillin for 10 days. No difference in the rate of recovery between treated and control groups was noted with respect to the frequency of paroxysms of coughing, whooping, episodes of vomiting and suctioning required and pulmonary complications. These results are consistent with those of the few controlled studies in the literature, namely, that pertussis immune globulin is of no value in treatment at this stage of pertussis.

Original languageEnglish (US)
Pages (from-to)203-208
Number of pages6
JournalThe Journal of pediatrics
Volume79
Issue number2
DOIs
StatePublished - Aug 1971
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Treatment of pertussis with pertussis immune globulin'. Together they form a unique fingerprint.

Cite this